School of International Business, China Pharmaceutical University, Jiangsu, China, China (People's Republic)
Disclosure information not submitted.
4D-01 - Cost-Effectiveness Analysis of Novel Oral Anticoagulant and Vitamin K Antagonist for the Anticoagulant Treatment of Chinese Patients with Postoperative Atrial Fibrillation: A Comparative Study Using Real-World Data
Monday, August 25, 20254:15 PM - 4:30 PM ET
